advanced search

Sonceboz

Sonceboz designs, develops and produces mechatronic drive systems. In the medical/pharmaceutical sector, it provides motors for drug delivery systems such a wearable injectors, dual cartridge injection and automatic reconstitution, as well as developing a proprietary wearable injector platform.


Visit Website

Headquarters
Sonceboz SA
Rue Rosselet-Challandes 5
2605 Sonceboz-Sombeval
Switzerland

Phone / Contact

T: +41 32 488 11 11
F: +41 32 488 11 00
E: [email protected]

Connect

Sonceboz designs, develops and produces mechatronic drive systems with linear or rotary movement, which use contactless electromagnetic technology. The company specialises in several markets: passenger cars, commercial vehicles, agricultural machinery and medical/pharmaceutical, as well as other industrial applications.

Its medical/pharmaceutical offering includes drive systems for wearable on-body injectors, medical devices and laboratory industrial solutions. Sonceboz is ISO 13485 and ISO 14001 certified.

Pharma companies looking for large volume injectors for high viscosity drugs, dual cartridge or auto-reconstitution injectors will find interesting solutions in Sonceboz’s new drug delivery device platform. Customised technology modules like motor-drives, electronics, pumps and needle insertion systems are available for medical device manufacturers.

Sonceboz is an privately owned family business. It was founded in 1936 and has more than 1000 employees.

0

Articles by Sonceboz

WEARABLES
Thomas Mayer
COMPARISON OF MECHATRONIC VS MECHANICAL WEARABLE DRUG DELIVERY SYSTEMS
Thomas Mayer, Nicolas Bailo and Martin Liniger highlight some of the key challenges that mechanical and mechatronic drug delivery systems must overcome when delivering large volumes of biologics subcutaneously and explain the solutions that Sonceboz has considered during the development process of the company’s large-volume injector.
WEARABLES
Thomas Mayer
ACCELERATING DEVELOPMENT OF SUBCUTANEOUS DELIVERY OF LARGE-VOLUME BIOLOGICS
Tom Mayer discusses how Sonceboz’s vial-based on-body injector – the LVI-V – can expedite the launch of large-volume SC delivery of biologics by leveraging existing primary container technology, reducing associated risks and total cost of ownership.
WEARABLES
Thomas Mayer
REPOSITIONING FROM IV TO VIAL-BASED SC FOR LARGE-VOLUME BIOLOGICS
Tom Mayer discusses the growing trend of moving away from intravenous drugs administered in clinical and hospital settings to at-home, self-administered vial-based subcutaneous delivery for cost savings, better lifecycle management and improved care.
WEARABLES
Thomas Mayer
NEXT-GENERATION WEARABLE DELIVERY DEVICES FOR LARGE-VOLUME BIOLOGICS
Thomas Mayer discusses Sonceboz’s platform of wearable injection devices for large-volume biologics, which can follow drugs from clinical trials to commercial phase through lifecycle management, which reduces risk and speeds time to market.
WEARABLES
Thomas Mayer
DRUG DELIVERY MEETS AUTOMOTIVE ENGINEERING
Thomas Mayer discusses Sonceboz’s activity in the world of wearable injectors and how the company’s experiences in the automotive industry and its in-house development of high-quality motors provide significant advantages for the design and production of wearable devices.
Top